AXIM BIOTECHNOLOGIES, INC. (AXIM) Free cash flow 2014–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.0MFY2023 · since FY2014: -$338,999 → -$1.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$1.0M | +49.8% |
| FY2022 | -$2.1M | +18.8% |
| FY2021 | -$2.5M | +23.7% |
| FY2020 | -$3.3M | — |
| FY2016 | -$1.3M | +16.8% |
| FY2015 | -$1.6M | -359.0% |
| FY2014 | -$338,999 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice